Purpose: To investigate the effect of symptom duration in pseudophakic primary rhegmatogenous retinal detachment (RRD) with or without macular involvement on functional and anatomical outcome during first-year follow-up. Procedures: Retrospective review of cases with pars plana vitrectomy for retinal detachment repair. Symptom duration, functional outcome, and redetachment rates were analyzed. Symptom duration was grouped (1-3, 4-7, 8-14, 15-30, >30 days) and correlated to outcome in the first year of follow-up. Results: 371 macula-off and 230 macula-on RRDs could be included. In macula-off RRDs, longer symptom duration was associated with higher redetachment rates (10-21%; p = 0.032). Patients presenting symptoms for less than 8 days showed significantly lower rates than those with a longer symptom duration (p = 0.046). In macula-on RRDs, symptom duration and outcome were not associated (p > 0.6). Conclusions: In macula-off RRD, early reattachment surgery is necessary to lower the risk for retinal redetachment. The aim in macula-on RRD is to prevent conversion to a macula-off situation.

Keywords:
Retinal detachment, rhegmatogenous, Pseudophakia, Symptom duration, Visual outcome, Redetachment rate
1.
Wykoff CC, Flynn HW, Jr, Scott IU: What is the optimal timing for rhegmatogenous retinal detachment repair? JAMA Ophthalmol 2013;131:1399-1400.
2.
Mitry D, Awan MA, Borooah S, Syrogiannis A, Lim-Fat C, Campbell H, Wright AF, Fleck BW, Charteris DG, Yorston D, Singh J: Long-term visual acuity and the duration of macular detachment: findings from a prospective population-based study. Br J Ophthalmol 2013;97:149-152.
3.
Goezinne F, La Heij EC, Berendschot TT, Kessels AG, Liem AT, Diederen RM, Hendrikse F: Incidence of redetachment 6 months after scleral buckling surgery. Acta Ophthalmol 2010;88:199-206.
4.
Doyle E, Herbert EN, Bunce C, Williamson TH, Laidlaw DA: How effective is macula-off retinal detachment surgery. Might good outcome be predicted? Eye (Lond) 2007;21:534-540.
5.
Heussen N, Hilgers RD, Heimann H, Collins L, Grisanti S; SPR study group: Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR study): multiple-event analysis of risk factors for reoperations. SPR study report no. 4. Acta Ophthalmol 2011;89:622-628.
6.
Hassan TS, Sarrafizadeh R, Ruby AJ, Garretson BR, Kuczynski B, Williams GA: The effect of duration of macular detachment on results after the scleral buckle repair of primary, macula-off retinal detachments. Ophthalmology 2002;109:146-152.
7.
Ho SF, Fitt A, Frimpong-Ansah K, Benson MT: The management of primary rhegmatogenous retinal detachment not involving the fovea. Eye (Lond) 2006;20:1049-1053.
8.
Wykoff CC, Smiddy WE, Mathen T, Schwartz SG, Flynn HW Jr, Shi W: Fovea-sparing retinal detachments: time to surgery and visual outcomes. Am J Ophthalmol 2010;150:205-210.e2.
9.
Geller SF, Lewis GP, Fisher SK: FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Müller and RPE cells. Invest Ophthalmol Vis Sci 2001;42:1363-1369.
10.
Oshima Y, Yamanishi S, Sawa M, Motokura M, Harino S, Emi K: Two-year follow-up study comparing primary vitrectomy with scleral buckling for macula-off rhegmatogenous retinal detachment. Jpn J Ophthalmol 2000;44:538-549.
11.
Ross WH, Kozy DW: Visual recovery in macula-off rhegmatogenous retinal detachments. Ophthalmology 1998;105:2149-2153.
12.
Frings A, Markau N, Katz T, Stemplewitz B, Skevas C, Druchkiv V, Wagenfeld L: Visual recovery after retinal detachment with macula-off: is surgery within the first 72 h better than after? Br J Ophthalmol 2016, DOI: 10.1136/bjophthalmol-2015-308153.
13.
Hartz AJ, Burton TC, Gottlieb MS, McCarty DJ, Williams DF, Prescott A, Klein P: Outcome and cost analysis of scheduled versus emergency scleral buckling surgery. Ophthalmology 1992;99:1358-1363.
14.
Enders P, Schick T, Schaub F, Kemper C, Fauser S: Risk of multiple recurring retinal detachment after primary rhegmatogenous retinal detachment repair. Retina 2016, Epub ahead of print.
15.
Holladay JT: Visual acuity measurements. J Cataract Refract Surg 2004;30:287-290.
16.
Salicone A, Smiddy WE, Venkatraman A, Feuer W: Visual recovery after scleral buckling procedure for retinal detachment. Ophthalmology 2006;113:1734-1742.
17.
Polkinghorne PJ, Craig JP: Analysis of symptoms associated with rhegmatogenous retinal detachments. Clin Experiment Ophthalmol 2004;32:603-606.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.